发明公开
EP2673237A4 MICROPOROUS ZIRCONIUM SILICATE FOR THE TREATMENT OF HYPERKALEMIA
审中-公开
MIKROPORÖSESZIRKONSILIKAT ZUR BEHANDLUNG VONHYPERKALIÄMIE
- 专利标题: MICROPOROUS ZIRCONIUM SILICATE FOR THE TREATMENT OF HYPERKALEMIA
- 专利标题(中): MIKROPORÖSESZIRKONSILIKAT ZUR BEHANDLUNG VONHYPERKALIÄMIE
-
申请号: EP12744254申请日: 2012-02-10
-
公开(公告)号: EP2673237A4公开(公告)日: 2014-12-31
- 发明人: KEYSER DONALD JEFFREY , GUILLEM ALVARO F
- 申请人: ZS PHARMA INC
- 专利权人: ZS PHARMA INC
- 当前专利权人: ZS PHARMA INC
- 优先权: US201161441893 2011-02-11
- 主分类号: C01B33/20
- IPC分类号: C01B33/20 ; A61K9/14 ; A61K33/00 ; A61K33/24 ; A61K45/06 ; B01J19/00 ; B01J19/18 ; B01J39/02 ; B01J39/14
摘要:
The present invention relates to novel microporous zirconium silicate compositions that are formulated to remove toxins, e.g. potassium ions, from the gastrointestinal tract at an elevated rate without causing undesirable side effects. The preferred formulations are designed avoid increase in pH of urine in patients and/or avoid potential entry of particles into the bloodstream of the patient. Also disclosed is a method for preparing high purity crystals of UZSi-9 exhibiting an enhanced level of potassium exchange capacity. These compositions are particularly useful in the therapeutic treatment of hyperkalemia.
信息查询